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The human CD2 (T11) molecule is a 50-kD surface glycoprotein expressed on
>95To of thymocytes and virtually all peripheralT lymphocytes that mediates both
adhesion between these cells and their cognate partners, as well as subsequent acti-
vation events . Specific combinations of antibodies against the surface-bound mole-
cule can activate IL-2-dependentT cell proliferation, helper T cell function, and
cytotoxicity byNK cells andCTL (1-3) in the absence ofcellular adhesion . In addi-
tion, thymocyte activation can be mediated viaCD2 (4, 5) . The role ofCD2 in ap-
proximation ofTcells to various cell types, including human thymic epithelial cells,
B cells, target cells, and sheep erythrocytes has been demonstrated to depend on
direct interaction betweenCD2 and the broadly distributed human LFA-3 surface
glycoprotein or its sheep homologue, T11TS (5-10) .
Biochemical analyses using specificmAbs show that CD2 isTlineage specific and
exists on the cell surface in several differentially glycosylated forms (11-13) . CD2
cDNA clones predict acleaved signal peptide of 24 amino acid residues, an extracel-
lularsegment of 185 residues, atransmembrane domain of 25 residues, and a cyto-
plasmic region of 117 residues (13-16) . The corresponding genomic organization re-
veals a single exon encoding thesignal peptide (less four residues), twoexonsencoding
the extracellular segment, one exon encoding thetransmembrane domain andcharged
membrane anchor segment, and one exon encoding the cytoplasmic region (17) .
A prerequisite for in-depth structure-function analysis of cell surface receptors
is the capacity to produce and analyze sufficient quantities of material that bear a
high degree of fidelity to the native structure. Preliminary observations suggested
that a baculovirus expression system could provide such a capability. However, due
to the nature of the cDNA construction, monomeric CD2 was not obtained . Here
we report theproduction and characterization of a recombinant soluble CD2 mole-
cule, termed T11,X2, that corresponds to the two extracellular segment exons and
exists in solution entirely in monomeric form . The folding of the recombinant CD2
protein appears to be native since it reacts with mAbs that were produced against
transmembraneCD2 on the surfaceofhumanTlymphocytes . Surprisingly, the affinity
of the CD2 extracellular segment monomer is only micromolar, implying that the
avidity of CD2-mediated Tcell adhesion is dependent on cooperative binding resulting
from the multiple copies ofCD2 on the T lymphocyte surface. To our knowledge,
this represents the first time that a lymphoid adhesion receptor has been produced
on a milligram scale in a functional and pure form .
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Materials and Methods
Baculooirus Transfer Vector Plasmid Constructfor Tllex2.
￿
The plasmid pAc373/Tllex2 was con-
structed by digestion of pGEM-4-Sl, a pGEM derivative containing a 950-bp fragment of
the CD2 cDNA PB2 (13) with Pvu II, which digests the cDNA at nucleotide position 628
near thestartof thetransmembrane region. Adouble-stranded synthetic oligonucleotidelinker:
CTGTCCAGAGAAATAAGGATCCT
GACAGGTCTCTTTATTCCTAGGA
containing the last base for the Ser-178 codon, codons for Cys-Pro-Glu-Lys, a stop codon,
and a Bam HI restriction site was synthesized and ligated to the blunt Pvu II ends. After
Bam HI digestion, the insert was cloned into the Bam HI site of the pAc373 baculovirus
transfer vector (18). All restriction enzymeswere purchased from NewEnglandBiolabs (Beverly,
MA).
Recombinant Protein Production.
￿
Transfer of the Tllex2 sequences from the plasmid vector
to the AcNPV genome to generate recombinant baculovirus Tllex2-AcNPV was accomplished
essentially as described (18, 19). Metabolic labeling with ["S]cysteine of Tllex2-AcNPV
infected SF9 cells was carried out as described (19). Metabolically labeled culture superna-
tants were harvested, microfuged for 10 min and subjected to immunoprecipitation for 16 h
at 4'C with a monoclonal anti-CD2 antibody (anti-T11,, 3T4-8B5) linked to Affigel-10 (Bio-
Rad Laboratories, Richmond, CA)beads(10 mg mAb/ml gel). Afterimmunoabsorption the
beads were washed twice with lysis buffer and bound material eluted with 0.1 M glycine,
HCl buffer, pH 2. Eluateswere analyzed by SDS-PAGE in 12 .5% gels. Large proteinproduc-
tion was performed as described (19), except that proteins were purified over an anti-T11 1
(3T4-8B5) immunoaffinity column.
Protein Microsequencing
￿
Proteins were prepared for microsequencing by electrophoresis
on 12.5% polyacrylamide gels, followed by electroblotting onto polyvinylidene difluoride mem-
branes accordingto themethod ofMatsudaira (20). Aftervisualizationwith Coomassieblue,
stained bands were excised and loaded onto a sequencer (No. 470; Applied Biosystems, Inc.,
Foster City, CA) and sequenced using the 03RPTH program.
Endoglycosidase FDigestion of Tlla2.
￿
1 kg samples of purified Tllex2 dialyzed against PBS
were incubated in Endo-F buffer (0.1 M sodium phosphate, 1% NP-40, 1% 2-ME, 50 mM
EDTA, 1 mM PMSF,pH 6.1) in thepresence of0.7 UEndo-F (New EnglandNuclear, Boston,
MA) in 7 ul reaction volumes. Digestion was arrested at the indicated times by addition of
15 11 SDS sample buffer, boiling for 5 min andfreezing at -20°C before analysis by 12 .5%
SDS-PAGE.
Equilibrium Sedimentation.
￿
Sedimentation studies were performedby usingtheshortcolumn,
high speed meniscus-depletion method ofYphantis (21) andRichardson et al: (22). Standard
double-sector cells, equipped with sapphire windows, 4-mm solution column lengths, and
a temperature of 21°C were used.
Papain Digestion.
￿
32 ng papain was added to 8 kg samples of T11-2 at 0.5 Ag/mI in PBS
containing 10 mM DTT for an enzyme/protein ratio of 1:250. Samples were incubated at
37 °C for 15, 30, 45,or 60 min. Digestions were stoppedby the addition ofSDS sample buffer
and boiling for 5 min. Samples were electrophoresed on a 12 .5% polyacrylamide gel and
stained with Coomassie blue.
CircularDichroism.
￿
Far ultraviolet CD spectrawere obtained on an Instruments S.A., Inc.,
(Metuchen, NJ)JobinYvon circular dichrograph calibrated with (+)10-camphorsulfonic acid
and epiandosterone. Measurements were taken at 25, 50, and80'C t 0.1°C in 10 mM so-
dium phosphate, pH 7.2, in a 1-mm cell. All spectra represent an average of three to five
individual spectra with data taken at 0.5-mm intervals using a 10-s response time for each
point. Protein concentrations were determined by quantitative amino acid analysis of ali-
quots taken from the sample cells.
Rosette Inhibition Assay.
￿
Jurkat cells were washed in supplemental MEM (SMEM)/2% FCS
(wash) and resuspended at 10'/ml. Sheep erythrocytes were washed twice in HBSS and
resuspended in wash to 517o vol/vol. 10 Al ofsheep erythrocytes were aliquotedinto 12-75-mm
plastic tubes and 100 14 wash, Tllex2 protein or control soluble CD4 T4ex1 protein (19) wasSAYRE ET AL.
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added, followed by incubation at 4 °C for 30 min. Subsequently, 20 p.l ofJurkat cells were
added, and after 5 min they were centrifuged at 800 rpm in a Sorvall RT6000, followed by
incubation at 4°C for 1 h. The cell mixture was gently resuspended and mounted on glass
slides with cover slips and rosette formation was assessed on a Zeiss photomicroscope.
Radiolabeled TI1.2 Binding Assays.
￿
The purified recombinant soluble CD2 external do-
main molecule Tll,.2 was radioiodinated as follows: 50 pl TlleX2 (1 mg/ml) dialyzed against
PBS was labeled with 10 kl of immobilized lactoperoxidase/glucose oxidase (Enzymobeads;
Bio-Rad Laboratories) in 40 mM sodium phosphate, pH 7.2, 0.4% glucose, and 1 MCi 1251
for 5 min. After quenching the reaction for 20 min with 20 mM sodium iodide and 0.0270
sodium azide, 20 Al FCS was added and the free iodine was separated on a 1-ml Bio-Gel
P-6 column (Bio-Rad Laboratories) conditioned with 0.2M sodium phosphate, pH 7.2, and
10% FCS and run in the same buffer.
Cold Competition Studies.
￿
5 x 106 cpm radiolabeled Tll,.2 (2.8 x 108 cpm/nmol) was added
at 0.1 pM to 1 .8 x 106JY cells overlayed onto 0.2 ml of a 1.5:1 mixture of dibutyl phthal-
ate:dioctyl phthalate (Aldrich Chemical Co., Milwaukee, WI) in 0.5-ml plastic tubes as de-
scribed in Teshigawara et al. (23). Increasing concentrations of unlabeled Tll,.2 or T4ex1 were
added in a final volume of 200 Ftl in RPMI 1640/10% FCS. After a 1-h incubation at 4°C,
the tubes were centrifuged (8,500 g for 1 min), the tips ofthe tubes containing the cell pellets
were cut, and the cell-bound and free radioactivity were determined in a gamma counter.
To some tubes, anti-LFA-3 antibody TS2/9 (generously provided by Dr. Timothy Springer,
Dana Farber Cancer Institute, Boston, MA) was added at 50 jig/ml as a separate determina-
tion of nonspecific binding. This concentration of anti-LFA-3 was independently shown to
give maximal inhibition of Tll,.2 binding. Specific activity was calculated using a molec-
ular weight for Tll,.2 of 30,000. Protein concentrations were determined by quantitative
amino acid analysis of standard Tll,.2 samples. Subsequent samples were compared with
standards by Coomassie blue staining of twofold dilutions of standard and test samples run
on the same gel and analyzed by densitometry.
Saturation Binding Studies.
￿
Increasing concentrations of radiolabeled Tllex2 (1.31 x 10 7
cpm/nmol) were added to 2 .6 x 10 6JY cells in the presence or absence of 50 Kg/ml anti-
LFA-3 antibody to determine nonspecific binding. Binding was carried out as above and the
dissociation constant was determined by Scatchard analysis after subtraction of nonspecific
binding determined in the presence of anti-LFA-3 .
Results
Production and Purification of T11ex2.
￿
We designed a construct for expression of a
soluble fragment of CD2 that would include all the residues encoded by the leader
and two extracellular segment exons (Fig. 1, exons 1-3). The plasmid pAc373/TlleX2
was constructed as described in Materials and Methods and encodes 182 amino acids
of the predicted CD2 external segment including all the residues derived from the
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two extracellularexons(Fig. 1) andpart of onecodon(for Glu-181) and allof a second
codon (for Lys-182) derived from the transmembrane domain exon . This construc-
tion thus includes all four extracellular cysteine residues located indomain II ofCD2
and thereby avoids problems associated with intermolecular disulfide exchange ob-
served with a previous construction (24) .
Plasmid pAc373/T11 e,,2 was used to co-transfect SF9 cells with AcNPV baculoviral
DNA. Recombinant baculovirus, termed Tllex2-AcNPV, were selected, purified,
and used to infect small-scale cultures for metabolic labeling . Immunoprecipitation
of radiolabeled supernatants with antiT11 t (3T4-8B5), an anti-CD2-specific mAb
(1), verified that Tllex2-AcNPV directed the production of a recombinant CD2 mol-
ecule in SF9 cells (data not shown) . Tllex2-AcNPV was therefore used to infect liter
cultures for the production oflarge amounts of protein . T11,X2 protein was purified
from infected cell supernatants by affinity chromatography on an antiT11 t column .
Biochemical Characterization of Tllex2 .
￿
Tllex 2 migrates as a well-demarcated dou-
blet in both reducing and nonreducing conditions in SDS-PAGE (Fig . 2, lanes a
and b) . Two well-separated bands at 30-31 kD are seen in the presence of 50 mM
ofDTT (lane a), which migrate at 27-28 kD in the absence of reducing agent (lane
b) . Theclear-cutdecrease in electrophoretic mobility afterreductionwithDTTstrongly
indicates that T11,X2 contains intrachain disulfide bridges ; it does not form inter-
chain bridges. Although not shown, microsequencing analysis of ["S]cysteine-
labeled peptides verifies that there are two sets of intrachain disulfidebonds in Tll ex2
between the NH2-terminal cysteines and COON-terminal cysteines .
FIGURE 2 .
￿
Purification, radio-
iodination, and endoglycosidase
digestion of Tllex 2. Lanes a-d :
1 Rg Tllex2 purified from large
scale cultures of SF9 cells in-
fected with Tllex2-AcNPV was
analyzed by Coomassie staining
on a 12.5% polyacrylamide gel
in the presence of 50mM DTT
(lane a) or in nonreducing con-
ditions (lane b) . An aliquot of
Tll ex 2 radioiodinated with
solid-phase lactoperoxidase/glu-
cose oxidase was analyzed on
the same gel in the presence
(lane c) or absence (lane d) of 50
mMDTTby autoradiography.
Lanes e-k: 1 kg purified Tll ex2
was digested with 0.7UEndo-F
for varyingamounts oftime and
the reaction wasstopped by the
addition of SDS sample buffer
before SIDS-PAGE analysis and
Coomassie staining. (Lane e)
No enzyme ; (lanef) simultane-
ous addition of enzyme and
samplebuffer; (lanesgj) 1 min,
5 min, 1 h, 18 h digestion ; (lane
k) 0 .7 U Endo-F alone .To investigate the difference between the two bands representing T11ex2, 160 pmol
ofpurified protein was separatedby SDS-PAGE and blotted onto apolyvinyl difluo-
ride (PVDF) membrane (20). The upper and lowerbands were cut separately from
the membrane for NH2-terminal sequencing. Each band yielded the CD2 NH2-ter-
minal sequence, suggesting that they differ from one another by posttranslational
modification. As shown in Fig. 2, endoglycosidase digestion generates at least five
distinct bands. After short digestion times, two new lower molecular weight species
are generated (lanesf-k). Some glycans on T11,.2 are apparently quite susceptible
to digestion since even aftersimultaneous addition ofenzyme and SDS sample buffer,
these new species are generated (lanef). After 1 h digestion, most ofthe T11ex2 pro-
tein is digested to a 25-kD species (lane i); overnight digestion results in complete
digestion to a single band at 25-kD (lanej). Note that the band of approximately
45-kDsizerepresents theEndo-F enzyme sinceitappears inlanek, where an equivalent
amount of enzyme alone has been analyzed. The origin ofthe faint band at 48-kD
in laneJ is unclear.
To determine whether T11,x2 exists as a noncovalently linked multimer in aqueous
solution, it was subjected to equilibrium sedimentation by the high-speed meniscus
depletion method (21) in both aqueous and dissociating conditions. As shown in
Fig. 3, thecalculated molecular weightsfor bothconditions are verysimilar(25.3 kD
in aqueous solutionvs. 24.7 kD in dissociating conditions). This result demonstrates
that T11,x2 exists as a monomer in solution.
The expression ofCD2 epitopes was investigated by immunoprecipitation anal-
ysis. The Tllex2 molecule can be immunoprecipitated by both anti-T11, and a
second mAb to a different epitope termed antiT112. However, T11,x2 is not immu-
noprecipitated by the anti-CD2 antibody anti-T113, which defines an activation
specific epitope on CD2. Nevertheless, T11,x2 was able to inhibit the binding of anti-
T113-FITC to the T113+ Jurkat cell line at a concentration of 10 AM, implying its
presence on T11ex2 (data not shown) . These results also suggest that the affinity of
anti-T113 for its epitope is low.
J
3.5
2.5
2.0
49
￿
50
￿
51
￿
52
rz(anpl
SAYRE ET AL.
￿
999
FIGURE 3.
￿
Equilibrium sedimentation analysis. Plots of
log (fringe displacement) against square of distance from
center ofrotation, r2. T11ex 2(0.05%) was analyzed by sedi-
mentation equilibrium on an analytical ultracentrifuge
(model E; Beckman Instruments, Fullerton, CA) in aqueous
solution (PBS) at 30,000 rpm (w = 3.142 x 103 rad/s) or
in dissociating conditions (6 M guanidine hydrochloride)
at 44,000 rpm (w = 4.608 x 103 rad/s). Data were obtained
at 22 °C (PBS) or 23°C (guanidine-hydrochloride). Assum-
ing a partial specific volume of 0.725, the calculated molec-
ular weight from the displayed slope and using the equa-
tion: molecular weight = 4.606 RT slope/[w2 (1 - trw)] is
225,315 in aqueous solution. Assuming a partial specific
volume (denoted asa) of0.725 - 0.1 in 6 M guanidine-hydro-
chloride (22), the calculated molecular weight is 24,736 in
dissociating conditions.1000
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Secondary structure predictions suggest the presence ofboth a-helical and /3-sheet
structure in the CD2 external domain (16). To more directly predict secondarystruc-
tural characteristics, the Tlle,,2 molecule was evaluated by circular dichroism. As
shown in Fig. 4 A, the far ultraviolet CD spectrum of Tlle,2 in 10 mM of sodium
phosphate shows a positive absorption maximum at about 200 nm (De = 0.459),
anegative minimum at 215 nm (De = -1.94), and ashoulder at 225 nm (Ae = -1.0).
When the T11,.2 molecule is reduced by 50 mM DTT and subsequently alkylated
with iodoacetamide, the CD spectrum is substantially altered, pointing to a role for
disulfide bridges in stabilizing secondary and tertiary structure (Fig. 4 B). The fact
that the spectrum of thenonreduced molecule reflects significant thermaldenatura-
tion at 80°C (Fig. 4 C) confirms that substantial secondary structure is present in
soluble TlleX2 . As expected, the pattern after thermal denaturation is the same for
the reduced as for the nonreduced molecule (compare Fig. 4, C and D).
In its overall pattern, the CD spectrum resembles that for Thy-1 (25), which is
a well-recognized member of the Ig superfamily (26) and is therefore predicted to
consist entirely of/3-sheet. However, the shoulder at 225 nm is absent from the Thy-1
profile. To obtain a more objective prediction of secondary structure from the CD
spectrum, the digitalized absorption data (Table 1) were deconvoluted according to
the inverse matrix method of Compton andJohnson (27). The resultingpredictions
forproportions of secondary elements are: a-helix, 20%; antiparallel /3-sheet, 13%;
parallel /3-sheet, 9% ; turn, 20%; other, 46%. Since none of the proteins in the data
setused to determine the matrix values are homologous to CD2, the predicted frac-
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Circular dichroism spectra ofTlleX 2 . Far ultraviolet circular dichroism spectrarep-
resent the average of three to five individual spectra with data taken at 0.5 nm wavelength in-
tervals in 10 mM sodium phosphate, pH 7.2. (A) Spectrum at 25°C of untreatedTlle,2; (B) spec-
trum of TlleX2 reducedwith 10 /AM DTTand alkylated with 20 pM iodoacetamide; (C) thermal
denaturation of the sample in A; (D) thermal denaturation of the sample in B.
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TABLE I
Digitized Protein Circular Dichroism Spectrum for Tller2 from
184-260 nm at 2-nm Intervals
Spectrum was taken in 10 mM sodium phosphate (pH 7.2) in a 1-mm cell at
22°C. Secondary structure predictions were calculated by taking dot products
with inverse CD spectra for the five secondary structure categories as described
previously (27); see Table Vl. Thecalculated results are: a-helix, 20%; antiparallel
/3-sheet, 13%; parallel Q-sheet, 9% ; turn, 20%; other, 46%. Units for AE are
M- 1/cm" 1.
tions of secondary structure are only approximate. When the same CD data are
deconvoluted by the method of Yang et al. (28), 15 1 /o tx and 40% a structures are
predicted.
To investigate the presence of protease-resistant domains in the Tllex2 molecule,
limitedpapain digestions were performed. 15 min ofdigestionat an enzyme/protein
ratio of 1:250 at 37°C yields a major band at 15 kD when analyzed by SDS-PAGE
(data not shown). Longer digestion times cause partial disappearance of the 15-kD
band. Approximately 400 pmol of this 15-kD material was blotted onto PVDF and
sequenced, yielding 19 unambiguous residues corresponding to the CD2 NH2 ter-
minus. These results demonstrate that the COOH region of T11,,,2 is much less
resistant to papain digestion that its NH2-terminal counterpart.
Tllex2 Inhibits Sheep Erythrocyte Rosetting
￿
We next tested the ability of Tllex2 to
interact with the CD2 ligand expressed on the surface of various cell types. The
capacity of Tllex2 to inhibit sheep erythrocyte rosetting with T lymphocytes was
tested. Table II shows that rosetting is completely inhibited at concentrations of
Tllex2 >5 AM; half-maximal inhibition occurs between 0.63 and 1.25 AM Tllex2.
Note that the anti-T111 (3T4-8B5) antibody abrogates rosetting at a concentration
as low as 0.007 AM (Table II). This results suggests that any direct interaction be-
tween the soluble Tllex2 molecule and the CD2 ligand is of relatively low affinity.
Wavelength De Wavelength Ae
184 -1 .49 224 -1 .002
186 -1 .50 226 -0-923
188 -1 .345 228 -0.856
190 -1 .176 230 -0.743
192 - 1 .026 232 -0,629
194 -0.284 234 -0.515
196 0.241 236 -0.426
198 0.411 238 -0.348
200 0.459 240 -0.282
202 0.360 242 -0.234
204 0.027 244 -0.195
206 -0.432 246 -0.151
208 -0.959 248 -0.112
210 - 1 .467 250 -0.089
212 -1 .750 252 -0.077
214 -1 .949 254 -0.062
216 -1 .930 256 -0.044
218 - 1 .771 258 -0.018
220 - 1 .515 260 -0.018
222 - 1 .2411002
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TABLE II
Concentration Dependence of TlleX2 Inhibition of
Sheep Erythrocyte-Human T Cell Rosettes
Rosettes
Protein added
￿
Amount
￿
(percent o£ control)
Tl 1-2
T4_,
Anti-CD2
For rosette formation, sheep erythrocytes were preincubated with soluble pro-
tein or antibody at the indicated concentrations for 1 h at 4°C followed by the
addition ofJurkat cells, cocentrifugation, and a further 1-h incubation at 4°C .
Rosettes were counted in a hemacytometer. Control value was the fraction of
rosette formation in the absence of added protein. Anti-CD2 was the anti-T11 i
antibody 3T4-8B5 .
TlleX2 Blocks the Binding ofAnti-LFA-3 mAb.
￿
To investigate whether T11,X2 could
interact with a previously defined ligand for CD2 on human cells (9), its ability to
blockthe binding of anti-LFA-3 mAb TS9/2 (29) to LFA-3-bearingcells was tested.
Specifically, anti-LFA-3 reactivity was measured by FACS analysis on the human
B-lymphoblastoid lineJY, which expresses high levels of LFA-3. As shown in Table
III, preincubation ofJY cells with soluble CD4 does not affect this staining, whereas
preincubation with 10 I.M TlleX2 causes a substantial decrease in observed fluores-
cence, reducing linear immunofluorescence from channel 120to 30.6. This represents
a reduction of 85% of specific anti-LFA-3 reactivity (calculated after subtraction
ofthe background fluorescence of 13.2 linear units). Significant blocking is also seen
at 1 j,M but not at 0.1 jM. Addition ofthe control soluble CD4 T4,.1 protein has
no effect on anti-LFA-3 binding. Thus, by this measure as well as by inhibition of
sheep erythrocyte rosetting, the affinity of TlleX2 for its ligand is apparently in the
micromolar range.
20
10
100
0
0
5 0
2.5 4.8
1.25 9.9
0.63 122
0.31 84
0.16 116
0.08 110
20 66
10 91
5 96
2.5 105
1 .25 90
0.63 72
0.31 110
0.16 99
0.08 116
0.7 0
0.07 0
0.007 0SAYRE ET AL.
TABLE III
Concentration Dependence of Tllex2 Inhibition ofAnti-LFA-3
Antibody Binding
Mean fluorescence intensities were obtained on a linear scale from 0 to 250.
Tllex2Binds to LFA-3 on Human BLymphoblastoidCells.
￿
SinceT11,.2 clearly inhib-
its sheep erythrocyte rosetting and blocks the binding of anti-LFA-3 antibody, we
determined whether specific, saturable binding of Tll ex 2 to human cells bearing
LFA-3 could bedetected. Twotypes ofbindingassays were used. In the first, increas-
ing amounts ofunlabeled T11,X2 was added to a mixture oftheJY B-lymphoblastoid
cell line plus a constant amount of 1251-labeled Tll ex2 (ligand). As shown in Fig.
5, binding of radiolabeled T11ex 2 is progressively inhibited by the addition of in-
creasing amounts ofunlabeled molecules. Half-maximal inhibition occurs at -0.5
14M of Tllex2 . In contrast and as expected, addition of soluble CD4 T4ex1 protein
has no effect on 1251-labeled Tllex2 binding to JY
n
￿
n
0 .I
￿
1
[T118x 2l l#Ml
"
10
1003
FIGURE 5.
￿
Competitive inhibition of
radioiodinated Tllex 2 binding to JY
cells. 5 x 106 cpm radiolabeled Tll ex2
(2.8 x 108 cpm/nmol) was added at 0.1
AM to 1.8 x 106 JY cells overlayed
onto 0.2 ml ofa 1.5:1 mixture ofdibutyl
phthalate/dioctyl phthalate in 0.5-ml
plastic tubes. Increasingconcentrations
of unlabeled Tllex2 (closed circles) or
T4_1 as a control (open circles) were
added in a final volume of 200 Pl in
RPMI 1640/10% FCS. After a 1-h in-
cubation at 4°C, tubes were spun, cell
pellets were severed, and bound radio-
activity was determined. To one tube
anti-LEA-3 antibody TS2/9 was added
at 50,ug/ml as a determination of non-
specific binding. Specific cpm are the
total cpm minus cpm bound in the pre-
sence ofanti-LFA-3 (9,070 cpm). Bind-
inginthepresence ofcontrol anti-HLA
mAb W6/32 is also shown (triangle).
Protein
added Amount
Anti-LFA-3
antibody added
Mean
fluorescence intensity
lsg1ml (IUM)
TI 1-2: 300 (10) + 30.6
30 (1) + 66.1
3 (0.1) + 109.1
0.3 (0.01) + 119.8
T4eX 1 : 300 + 125.1
30 + 120.2
3 + 117.6
0.3 + 116.9
None + 123.7
- 13.21004
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FIGURE 6 .
￿
Saturation binding of Tllex2 to
JY cells and Scatchard analysis . Increasing
concentrations of radiolabeled Tllex2 (1.31 x
10 7 cpm/nmol) were added to 2.6 x 106JY
cells in the presence or absence of 50 kg/ml
anti-LFA-3 antibody to determine nonspecific
binding . Bindingwas carried out as aboveand
the dissociation constant was determined by
Scatchard analysis after subtraction of non-
specific binding determined in the presence
ofanti-LFA-3 . (Top) Total binding (open circles)
and specific binding (closed circles) . (Bottom)
Scatchard analysis: correlation coefficient =
0.98 ; -1/slope = Kd = 0.4 pM .
As asecond measure of binding, increasing amounts of labeled Tllex2 were added
toaconstantnumber ofJY cells . Asshown in Fig. 6 (top), specific binding is saturable .
These saturation bindingdata were transformedby Scatchard analysis (Fig. 6, bottom).
Specific T11ex2 binding is saturated at -300 x 10 3 molecules per cell. The Scatchard
plot yields an estimated dissociation constant of 0.4 pM for the Tllex2-LFA-3 in-
teraction . Note that although a single incubation period (1 h at 4°C) of cells with
ligand was used in these experiments, kinetic analysis demonstrates that maximal
T1-1 e,2-LFA-3 binding occurs within 5 min.SAYRE ET AL.
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Discussion
We have shown that a soluble, monomeric extracellular segment CD2 molecule,
termed T11,.2, carries epitopes recognized by antibodies against the native surface
CD2 structure on resting Tlymphocytes and interacts specifically with the surface-
bound CD2 ligand LFA-3. The measured dissociation constant for this interaction
is 0.4 uM, implying a low affinity relative to hormone receptor-ligand interactions
(i.e., for IL-2 Kd = 10-11 M) (23) but equivalent to that of primary antibody re-
sponses (Kd = 10-5 to 10-6) (30). The T11,X2 molecule gives rise to a proteolyti-
cally resistant 15-kD N112-terminal papain fragment, suggesting that the NH2-ter-
minal -100 amino acid residues comprise a stable, well-folded domain corresponding
to a polypeptideencodedby thefirst extracellularexon. In contrast, despite disulfide
linkages, the COOH-terminal-encoded extracellular domain is labile to papain.
Binding ofMonomeric T11e,2 Is Less Avidthan that ofDetergent-solubilized CD2.
￿
The
dissociation constant presented here for the monomeric T11,X2 molecule contrasts
with the value of 50 nM reported for similar analyses on JY cells with a detergent-
solubilized full-length CD2 molecule purified from Tcells (9). In both casesthe esti-
mate of binding affinity derived by Scatchard analysis agrees quite well with that
obtained by inhibition with unlabeled ligand. The two distinct interactions mea-
sured likely display real affinity differences. In addition, blocking estimates of the
affinity of T11,X2 for its ligand by rosette inhibition, blocking of anti-LFA-3 anti-
body binding, either of two distinct radiolabeled binding assays and preliminary
studies ofT11,.2-mediated inhibition of clonal Tcell proliferation (data not shown)
all give results in the same range, i.e., a distinctly lower affinity that that reported
for detergent-solubilized CD2.
Several possibilities mayexplain thedifference in reported bindingaffinities. First,
the presence of thehydrophobictransmembrane segment in thepurified CD2 mole-
cule may endow it with adifferentbindingbehavior than the membrane-anchorless
T11,%2 protein. For example, it is possible that interaction of the transmembrane
segment with the cell Membrane affects the maximal affinity. Second, detergent-
solubilized CD2 Probably exists as detergent/protein micelles, which might allow
for a multivalent attachment of micelles to JY cells that could affect the observed
dissociation constant: Such multipoint attachment wouldnot be possible forthe mono-
meric TIle.2. However, one cannot rule out the possibility that T11ex2 fails to adopt
a conformation `sufficiently like that of the native CD2 molecule to allow it to bind
in a similarway. This mightresult from the absence of contributions from the trans-
membrane or cytoplasmic domains or differences in post-translational processing
by SF9 cells as compared with human T lymphocytes. This possibility is made less
likely by the fact that T11e.2 carries epitopes for anti-CD2 antibodies that inhibit
CD2-LFA-3 interaction and the unrelated T112 and T113 epitopes and by the fact
that SF9 cells correctly cleave the CD2 signal peptide.
The relatively low affinity of T11,X2 for LFA-3 needs to be viewed in the context
of thecell biology of this ligand-receptor pair in cell-cell interactions. Clearly, CD2
does not exist as a soluble monomer on Tcells, but rather as an array of cell-bound
transmembrane structures consisting of multiple copies percell, rangingfrom 20,000
on resting peripheral blood lymphocytes to 200,000 on activated T cells (13). Thus,
a high affinity interaction between one CD2 and one LFA-3 molecule may not be
required for a single binding event. Rather, a series of low affinity binding events1006
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could be sufficient for two cellsto adhere to one anotherby amultimeric interaction
that would greatly enhance the avidity of the T cell for its cognate partner. Antigen-
stimulated T cells express an order of magnitude more of surface CD2, perhaps
in order to adhere better to presenting cells in areas of ongoing immune responses.
Substantial indirect evidence exists to suggest that the CD4 molecules on helper
Tcells andclass II-restricted cytolytic Tcells interact with class II MHC molecules
on stimulator or target cells (31-33). Abrogation of this interaction by anti-CD4
or anti-class II antibodies profoundly influences T cell responses. The inability to
observe a direct physical interaction between CD4 and Ia and to inhibit cellular in-
teractions with micromolar amounts of soluble CD4 (19) suggests that low affinity
interactions are of fundamental significance for physiologic T cell function.
The Relationship ofCD2 to the Ig Superfamily.
￿
Several reports argue for the inclu-
sion ofCD2 in the Ig superfamily(26, 34, 35). The defining characteristic ofmembers
of this family is the presence of one or more Ig folds that comprise two 0-sheets,
each containing threeor four antiparallel a-strands, 5-10 amino acids in length. Nearly
all Ig folds contain an intrachain disulfide link. The fold is markedly resistant to
proteolysis which may reflect the need for Ig-like molecules to retain function in
extracellularspaces where they may be exposed to proteases. Immune system mole-
cules predicted to have at least one such domain include the MHC antigens, CD4
and CD8 structures, Thy-1 molecule, and poly-Ig receptor. A variety of cell surface
molecules found on cells outside the immune system have also been suggested to
belong to this family, including the NCAM and ICAM-1 cell adhesion molecules
and platelet-derived growth factor and CSF-1 receptors (reviewed in reference 26).
The exon-intron organization of CD2 divides its external segment into two do-
mains: I, amino acids 1-103; and II, amino acids 104-180. Consistent with this divi-
sion, limited papain digestion of soluble CD2 molecule T11e.2 clearly demonstrates
the existence of a stable NH2-terminal fragment of -100 residues. Both domains
I and II have been suggested to adopt Ig structures on the basis of primary sequence
homology with other Ig family members (26).
Although the alignmentscores forthese domainsare statistically significant when
tested against other members ofthe Ig superfamily, certain difficulties are apparent.
If both CD2 domains are Ig-like, the extracellular domain should not contain any
a-helical structure. However, earlier secondary structural predictions suggest thepres-
ence of a-helices, with a particularly strong prediction forthe NH2-terminal 10-20
residues (16). In addition, circular dichroism data for the Tlle.2 molecule, which
includes both domains, predict substantial (-20%) a-structure when analyzed by
either of two deconvolution methods. If this interpretation of the CD profile is cor-
rect, and if Tll,.2 adopts a configuration similar to native CD2, as is suggested by
its ability to be recognized by anti-CD2 antibodies and to bind specifically to a cell-
surface ligand for CD2, LFA-3, it would appear unlikely that both CD2 domains
adopt Ig folds.
Given that the 15-kD domain I fragment can be obtained in high yield from the
soluble CD2 molecule described here, it should be informative to analyze the frag-
ment alone by circular dichroism. Apparently, it also folds correctly since it can be
recognized by anti-T111 and antiT112 antibodies and inhibits sheep erythrocyte
rosetting to T cells (24). If the secondary structure predictions (16) are correct, this
analysis should reveal a mix of a-helical and /3-sheet structures. The availability ofSAYRE ET AL.
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both the entire extracellular segment and the fragment in large amounts could also
allow for crystallographic analysis.
The present report has emphasized the role of the CD2 external segment in
facilitating T lineage-specific cell adhesion. Clearly, this C132-dependent process
is critical for physiologic T cell function and thymocyte-thymic epithelial cell inter-
action. Given the lineage-restricted nature of the CD2 adhesion molecule and the
high level of LFA-3 expression on thymic epithelial cells (5), it is quite likely that
CD2 plays a major role in intrathymic differentiation.
Summary
The 50-kD CD2 (Tll) surface glycoprotein on human T lymphocytes and thymo-
cytes plays a critical role in T lineage cell activation and adhesion via its ligand LFA-
3. To begin to define structure-function relationships in the extracellular segment
ofthe transmembrane CD2 molecule, we have used a eukaryotic expression system
and a CD2 cDNA to produce milligram amounts ofrecombinant soluble CD2 mol-
ecule that corresponds to the two extracellular segment exons. We show that this
protein, termed Tll e,2, behaves as a monomer in aqueous solution and includes a
proteolytically resistant NH2-terminal fragment (domain I) encoded by the first ex-
tracellular segment exon. Circular dichroism analysis of T11e,2 demonstrates that
its stabilized secondary structure is dependent on the intrachain disulfide bonds present
in domain II. The Tll,.2 monomer binds directly to the CD2 ligand LFA-3 with
a dissociation constant of 0.4,uM. This relatively low affinity implies that coopera-
tive binding resulting from an array oftransmembrane CD2 molecules is important
to facilitate physiologic T cell adhesion.
We thank Drs. Kendall Smith for helpful discussions regarding binding analyses and Gerald
Fasman regarding circular dichroism. We also acknowledge the excellent technical assistance
of Neville Buttress, Amita Vaid, Yasmin Husain, and Ruth Steinbrich.
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